Drug
Ifosfamide clinical trials
Also written Ifex, MJF 9325 and Z-4942.
- studies test it
- 195
- open now
- 24
- in phase 3
- 41
- first study started
- 1990
Keep track of what changes. Save the Ifosfamide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
194 studies that test it; most in 2007 (13)
| Year | Studies |
|---|---|
| 1990 | 2 |
| 1992 | 2 |
| 1993 | 3 |
| 1994 | 5 |
| 1995 | 4 |
| 1996 | 4 |
| 1997 | 8 |
| 1998 | 7 |
| 1999 | 8 |
| 2000 | 7 |
| 2001 | 8 |
| 2002 | 2 |
| 2003 | 9 |
| 2004 | 10 |
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 13 |
| 2008 | 6 |
| 2009 | 11 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 39
- Phase 2
- 119
- Phase 3
- 41
- Phase 4
- 5
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 189
Memorial Sloan Kettering Cancer Center (16) · Children's Oncology Group (15) · M.D. Anderson Cancer Center (13) · National Cancer Institute (NCI) (9) · City of Hope Medical Center (7) · European Organisation for Research and Treatment of Cancer - EORTC (6) · St. Jude Children's Research Hospital (4) · Sun Yat-sen University (4)
Often tested with
Tested in the same studies.
Etoposide (99) · Doxorubicin (69) · Carboplatin (65) · Cisplatin (40) · Cyclophosphamide (37) · Vincristine (35) · Rituximab (26) · Paclitaxel (24)
Studies
Open first, then newest update. How each study uses Ifosfamide is read from its arms, and is right about nine times in ten.
Testing it · 195
- Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLRecruitingPhase 2New York Medical CollegeNCT02393157Written as Ifosfamide
- Sequential Neoadjuvant Chemotherapy in Soft Tissue SarcomaRecruitingPhase 2Oslo University HospitalNCT04776525Written as Ifosfamide
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaRecruitingPhase 2Mayo ClinicNCT03418038Written as Ifosfamide
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT07194044Written as Ifosfamide
- Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk WallNot yet recruitingPhase 3Ohio State University Comprehensive Cancer CenterNCT07823491Written as Ifosfamide
- N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06528496Written as Ifosfamide
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTRecruitingPhase 2Children's Oncology GroupNCT04322318Written as Ifosfamide
- Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit LymphomaNot yet recruitingPhase 2/3National Cancer Institute (NCI)NCT07724457Written as Ifosfamide
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaRecruitingEarly Phase 1New York Medical CollegeNCT03719105Written as Ifosfamide
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNot applicableM.D. Anderson Cancer CenterNCT04199026Written as Ifosfamide
- Drug Screening Using IMD in Bladder CancerEnrolling by invitationEarly Phase 1Brigham and Women's HospitalNCT06204614Written as Paclitaxel/Docetaxel/Ifosfamide
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymphomaRecruitingPhase 3University Hospital MuensterNCT04043494Written as Ifosfamide
- Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)RecruitingPhase 3Children's Cancer Group, ChinaNCT05681260Written as Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
- A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin LymphomaRecruitingPhase 2/3University of BirminghamNCT05991388Written as Ifosfamide
- Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCLNot yet recruitingNot applicableThe First Affiliated Hospital with Nanjing Medical UniversityNCT07389356Written as Rituximab+Ifosfamide+Mesna+Mitoxantrone hydrochloride liposome+Etoposide
- IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)RecruitingPhase 2Fudan UniversityNCT06849986Written as Tislelizumab+liposomal doxorubicin+ifosfamide
- Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)RecruitingPhase 2Swiss Cancer InstituteNCT06835049Written as Ifosfamide
- High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)RecruitingPhase 3Gustave Roussy, Cancer Campus, Grand ParisNCT04221035Written as Ifosfamide
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingPhase 3Martin SchrappeNCT03643276Written as Ifosfamide
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaRecruitingPhase 1/2University of BirminghamNCT04625907Written as Ifosfamide
See all 195 studies that test Ifosfamide →
Given in every arm · 98 — Ifosfamide is usual care beside what is tested
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaRecruitingPhase 1/2Hoffmann-La RocheNCT05533775Written as Ifosfamide
- Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaRecruitingPhase 2Milton S. Hershey Medical CenterNCT07321912Written as Ifosfamide
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTRecruitingPhase 2Children's Oncology GroupNCT04684368Written as Ifosfamide
- Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaRecruitingPhase 3Children's Oncology GroupNCT06647953Written as Ifosfamide
- NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)RecruitingPhase 1/2St. Jude Children's Research HospitalNCT06239272Written as Ifosfamide
- Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell LymphomaRecruitingPhase 2University of California, DavisNCT06905509Written as Ifosfamide
- A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07477457Written as Ifosfamide
- MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaRecruitingPhase 2HRYZ Biotech Co.NCT06277154Written as Ifosfamide
- Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCLRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06489808Written as Ifosfamide
- Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruitingPhase 1BeBetter Med IncNCT06164327Written as Ifosfamide for Injection
- A Study of Sulfatinib on Relapsed or Refractory Drug Resistant OsteosarcomaNot yet recruitingPhase 1/2Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05590572Written as Isophosphamide
- Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid TumorsNot yet recruitingPhase 1/2Samsung Medical CenterNCT03628131Written as Ifosfamide
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing SarcomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT02306161Written as Ifosfamide
- Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT02112916Written as Ifosfamide
- Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)Active, not recruitingPhase 2Institut BergoniéNCT04968106Written as Ifosfamide
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaActive, not recruitingPhase 3Children's Oncology GroupNCT03007147Written as Ifosfamide
- Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the BodyTerminatedPhase 2/3Children's Oncology GroupNCT06820957Written as Ifosfamide
- Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaCompletedPhase 1City of Hope Medical CenterNCT03440567Written as Ifosfamide
- Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsCompletedPhase 2St. Jude Children's Research HospitalNCT01946529Written as ifosfamide
- Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell LymphomaActive, not recruitingPhase 2David Bond, MDNCT05821088Written as Ifosfamide
Showing 20 of 98.
As the comparator · 6 — what is tested is compared with Ifosfamide
- Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruitingPhase 3BeBetter Med IncNCT06792253Written as Ifosfamide for Injection
- Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedPhase 3AmgenNCT02393859Written as Ifosfamide
- A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin LymphomaActive, not recruitingPhase 3Regeneron PharmaceuticalsNCT06230224Written as Ifosfamide
- Ph II Nintedanib vs. Ifosfamide in Soft Tissue SarcomaTerminatedPhase 2European Organisation for Research and Treatment of Cancer - EORTCNCT02808247Written as Ifosfamide
- An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)CompletedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00796120Written as Ifosfamide
- A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaCompletedPhase 2Istituto Clinico HumanitasNCT00636311Written as Ifosfamide, Gemcitabine, Vinorelbine
Codes
What other systems call Ifosfamide · ClinicalTrials.gg INT007647
- MeSH (NLM) D007069IfosfamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UM20QQM95YIFOSFAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 5657Confirmed FDA, Wikidata
- Wikidata Q418560ifosfamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C564IfosfamideOne source FDA
- DrugBank DB01181One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007069 | Ifosfamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UM20QQM95Y | IFOSFAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5657 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418560 | ifosfamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C564 | Ifosfamide | One source FDA |
| DrugBank | DB01181 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.